Betatrophin levels were analyzed in participants of the MesyBePo study follow-up cohort (Metabolic Syndrome Berlin-Potsdam) that included healthy control subjects as well as patients with impaired glucose metabolism including overt type 2 diabetes. Here, ANGPTL8 is linked to metabolic syndrome.